Tinefcon Tablets are a breakthrough, globally patented oral formulation designed to provide effective and safe relief from psoriasis and related inflammatory skin conditions. Powered by the clinically validated phytoactive extract of Sphaeranthus indicus, Tinefcon works through a unique, multi-target mechanism that down-regulates TNF-α and IL-12/IL-23 via the JAK-STAT pathway — offering powerful immunomodulatory benefits without the risks of toxicity or immunosuppression.
Clinically tested on over 500+ patients across Phase II and IV trials in India, Tinefcon has shown results comparable to conventional therapies such as Methotrexate, Cyclosporine, and Apremilast. It is ideal for both standalone treatment and maintenance therapy, ensuring long-term skin health and reduced psoriasis flare-ups.
Key Benefits of Tinefcon Tablets:
-
Helps restore red, scaly, flaky, and damaged skin associated with psoriasis
-
Relieves persistent itching, scaling, and dryness in inflammatory skin conditions
-
Reduces redness, irritation, and pain due to its anti-inflammatory properties
-
Modulates immune response and helps control chronic psoriasis flare-ups
-
Non-Toxic, Non-Immunosuppressive, and Hepatoprotective and safe for long-term use
Key Ingredient and Its Action:
Sphaeranthus indicus Extract (700 mg)
-
A powerful phytoactive ingredient with anti-inflammatory and immunomodulatory action
-
Inhibits key inflammatory cytokines (TNF-α and IL-12/IL-23) through the JAK-STAT pathway
-
Promotes significant improvement in PASI (Psoriasis Area and Severity Index) scores
Dosage and Directions for Use:
-
Therapeutic Dose: 2 tablets twice daily (2–0–2) after meals, for a minimum of 3 months
– Morning dose after a heavy breakfast, evening dose after dinner
-
Maintenance Dose: 1 tablet twice daily (1–0–1) after meals
For best results, use under the supervision of a healthcare professional. Tinefcon Tablets are also available as part of a complete psoriasis care regimen including topical creams, skin cleansers, and scalp cleansers.
General FAQs
Q1: What are the benefits of Tinefcon Tablets?
A: Tinefcon Tablets are specially formulated to manage psoriasis symptoms such as red, flaky, scaly, and inflamed skin. They help relieve itching, reduce inflammation, and promote healing of damaged skin while supporting immune balance to control flare-ups.
Q2: How does Tinefcon work in psoriasis treatment?
A: Tinefcon works by down-regulating key inflammatory cytokines like TNF-α and IL-12/IL-23 through the JAK-STAT pathway. This multi-target action helps in reducing psoriasis-related inflammation and skin damage.
Q3: What is the key ingredient in Tinefcon Tablets?
A: Each tablet contains 700 mg of clinically validated phytoactive extract of Sphaeranthus indicus, known for its powerful anti-inflammatory and immune-modulating properties.
Q4: How should Tinefcon Tablets be taken?
A: The recommended dosage is 2 tablets twice daily (2–0–2) after food for 3 months.
– Take the morning dose after a heavy breakfast
– Take the evening dose after dinner
For maintenance, the dose is 1 tablet twice daily.
Q5: Is Tinefcon safe for long-term use?
A: Yes, Tinefcon is Non-Toxic, Non-Immunosuppressive, and Hepatoprotective, making it safe for extended and maintenance therapy under medical guidance.
Q6: How soon can I expect results from Tinefcon?
A: Many users notice visible improvement in symptoms like itching, scaling, and redness within 3 to 4 weeks, with more significant improvements typically seen over a 12-week course.
Q7: Can Tinefcon Tablets be used with other psoriasis treatments?
A: Yes, Tinefcon can be used as a standalone therapy or alongside other topical treatments as part of a comprehensive psoriasis care regimen. Always consult a healthcare provider before combining treatments.
Q8: Are there any side effects of using Tinefcon Tablets?
A: Tinefcon has shown excellent safety in clinical trials with no serious side effects reported.
Q9: In what conditions Tinefcon should be avoided?
A: Tinefcon should be avoided during pregnancy, breastfeeding, or by those with known allergies to Sphaeranthus indicus. Always consult a physician before starting any new therapy.
Q10: What are the appropriate storage conditions for Tinefcon?
A: Store in a cool, dry place away from direct sunlight and moisture. Keep the bottle tightly closed and out of reach of children.
Q11: What dosage of tinefcon to be taken in case of relapse?
A: Psoriasis is a remitting—relapsing, auto-immune disease with no permanent cure.
Depending on the stimuli experienced and life style habits of the patient, he/she could get relapse of psoriasis. Patient needs to start with the full dosage of tinefcon i.e. (2—0—2) for 3 months.
Dermatologist FAQs
Q1: How does Tinefcon differ from conventional systemic therapies for psoriasis?
A: Tinefcon is the world’s first oral TNF-α and IL-12/IL-23 down-regulator derived from the phytoactive extract of Sphaeranthus indicus. Unlike immunosuppressants such as Methotrexate or Cyclosporin, it modulates inflammation via the JAK-STAT pathway without causing immunosuppression or hepatotoxicity.
Q2: What is the clinical evidence supporting the use of Tinefcon in psoriasis?
A: Tinefcon has been validated through Phase II and IV clinical trials involving over 500+ patients in India. Studies have demonstrated PASI score improvements comparable to Apremilast, Methotrexate, and Cyclosporin, while maintaining a superior safety profile.
Q3: What is the mechanism of action of Sphaeranthus indicus in Tinefcon?
A: The active extract targets multiple inflammatory pathways by down-regulating TNF-α and IL-12/IL-23 cytokines. It reduces skin inflammation through immunomodulation while promoting healing without suppressing the immune system.
Q4: What is the recommended dosage regimen for optimal outcomes?
A: For active treatment:
2 tablets twice daily (2–0–2) after meals for 3 months.
For maintenance:
1 tablet twice daily (preferably post-meals). A heavy breakfast is recommended before the morning dose to aid absorption.
Q5: Is the Tinefcon tablet safe to take over a long period of time?
A: Yes. Tinefcon tablets contain phytoactive ingredients and has no known interactions with other classical medications. Tinefcon is safe for Long term therapy – some of our patients are using tinefcon for more than 8 years.
Q6: Can Tinefcon be used in combination with topical therapies?
A: Absolutely. Tinefcon complements topical treatments and can be integrated into a combination regimen, especially during flare-ups, or for transitioning patients off immunosuppressive agents.
Q7: Is Tinefcon effective in all types of psoriasis?
A: Yes, Tinefcon is primarily studied for chronic plaque psoriasis but it has shown results in broader clinical use for All Types of Psoriasis, Including Scalp Psoriasis, Guttate Psoriasis, etc.
Q8: How soon do patients begin to see results with Tinefcon?
A: Symptom relief such as reduction in itching, scaling, and redness is typically observed within 3–4 weeks, with significant skin clearance over 12 weeks when taken consistently.
Q9: Are there any contraindications or known drug interactions?
A: Tinefcon is generally well-tolerated. However, caution is advised in pregnant or breastfeeding women, and in patients with known hypersensitivity to Sphaeranthus indicus. No significant drug interactions have been reported to date.
Q10: What monitoring is required during Tinefcon therapy?
A: Unlike traditional systemic agents, no routine liver, renal, or hematologic monitoring is needed due to its non-toxic and hepatoprotective nature. Still, clinicians may monitor symptom progression and patient compliance.
Q11: Is the Tinefcon Tablet acceptable for children to take?
A: No, the dosage is designed for individuals aged 12 and above. However, exceptions may be made under medical supervision. Tinefcon cream may be used for children under guidance from a healthcare professional.
